Identifying primary and recurrent cancers using a SAS-based natural language processing algorithm.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 3638182)

Published in J Am Med Inform Assoc on July 21, 2012

Authors

Justin A Strauss1, Chun R Chao, Marilyn L Kwan, Syed A Ahmed, Joanne E Schottinger, Virginia P Quinn

Author Affiliations

1: Kaiser Permanente Southern California, Research and Evaluation, Pasadena, California, USA.

Articles cited by this

A simple algorithm for identifying negated findings and diseases in discharge summaries. J Biomed Inform (2001) 21.03

Mayo clinic NLP system for patient smoking status identification. J Am Med Inform Assoc (2007) 3.92

Overcoming barriers to NLP for clinical text: the role of shared tasks and the need for additional creative solutions. J Am Med Inform Assoc (2011) 3.14

Machine learning and rule-based approaches to assertion classification. J Am Med Inform Assoc (2008) 2.76

Electronic health record systems and intent to apply for meaningful use incentives among office-based physician practices: United States, 2001-2011. NCHS Data Brief (2011) 2.36

Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst (2006) 2.34

Implementation and evaluation of a negation tagger in a pipeline-based system for information extract from pathology reports. Stud Health Technol Inform (2004) 2.16

Use of Medicare hospital and physician data to assess breast cancer incidence. Med Care (1999) 1.85

Natural language processing in the electronic medical record: assessing clinician adherence to tobacco treatment guidelines. Am J Prev Med (2005) 1.77

Description of a rule-based system for the i2b2 challenge in natural language processing for clinical data. J Am Med Inform Assoc (2009) 1.40

A rule-based approach for identifying obesity and its comorbidities in medical discharge summaries. J Am Med Inform Assoc (2009) 1.32

Natural language processing framework to assess clinical conditions. J Am Med Inform Assoc (2009) 1.31

Comparing methods for identifying pancreatic cancer patients using electronic data sources. AMIA Annu Symp Proc (2010) 1.25

MITRE system for clinical assertion status classification. J Am Med Inform Assoc (2011) 1.18

Automatic encoding into SNOMED III: a preliminary investigation. Proc Annu Symp Comput Appl Med Care (1994) 1.12

Health information technology: revisions to initial set of standards, implementation specifications, and certification criteria for electronic health record technology. Interim final rule with request for comments. Fed Regist (2010) 1.08

Coding free text radiology reports using the Cancer Text Information Extraction System (caTIES). AMIA Annu Symp Proc (2007) 1.07

Synoptic tool for reporting of hematological and lymphoid neoplasms based on World Health Organization classification and College of American Pathologists checklist. BMC Cancer (2007) 1.06

Natural language processing for the development of a clinical registry: a validation study in intraductal papillary mucinous neoplasms. HPB (Oxford) (2010) 0.98

Automatic SNOMED coding. Proc Annu Symp Comput Appl Med Care (1994) 0.87

Articles by these authors

Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 6.54

Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol (2007) 3.42

ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med (2011) 3.12

Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol (2007) 3.06

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA (2011) 2.77

Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J (2012) 2.55

High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst (2013) 2.46

Prevalence of extreme obesity in a multiethnic cohort of children and adolescents. J Pediatr (2010) 2.46

Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg (2007) 2.43

Environmental and genetic risk factors for childhood leukemia: appraising the evidence. Cancer Invest (2005) 2.36

Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA (2010) 2.30

Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control (2008) 2.14

Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev (2007) 1.94

Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet (2010) 1.74

Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer (2007) 1.71

Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med (2007) 1.65

Changes in serum prostate-specific antigen levels and the identification of prostate cancer in a large managed care population. BJU Int (2013) 1.62

Initial validation of an exercise "vital sign" in electronic medical records. Med Sci Sports Exerc (2012) 1.46

Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project. Breast Cancer Res Treat (2011) 1.36

Tobacco control efforts in managed care: what do the doctors think? Am J Manag Care (2004) 1.33

Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr (2012) 1.32

Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat (2009) 1.31

Body weight and height data in electronic medical records of children. Int J Pediatr Obes (2010) 1.29

Using probabilistic corrections to account for abstractor agreement in medical record reviews. Am J Epidemiol (2007) 1.22

Impact of breast cancer subtypes and treatment on survival: an analysis spanning two decades. Cancer Epidemiol Biomarkers Prev (2012) 1.22

Relationship between tobacco control policies and the delivery of smoking cessation services in nonprofit HMOs. J Natl Cancer Inst Monogr (2005) 1.22

Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study. PLoS One (2010) 1.16

Tobacco-control policies in 11 leading managed care organizations: progress and challenges. Eff Clin Pract (2002) 1.16

HIV infection and incidence of ischemic stroke. AIDS (2014) 1.15

Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat (2009) 1.15

The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics. Cancer Causes Control (2011) 1.15

Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol (2009) 1.14

Weight change and survival after breast cancer in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev (2012) 1.13

Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr (2014) 1.13

Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Res Treat (2013) 1.12

Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev (2014) 1.11

Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat (2012) 1.10

RE: Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741. J Natl Cancer Inst (2016) 1.10

Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med (2016) 1.10

Effects of physical activity and sedentary time on the risk of heart failure. Circ Heart Fail (2014) 1.09

Obesity and mortality after breast cancer by race/ethnicity: The California Breast Cancer Survivorship Consortium. Am J Epidemiol (2013) 1.07

Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer. J Am Coll Surg (2011) 1.07

Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care. J Acquir Immune Defic Syndr (2016) 1.05

Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev (2012) 1.04

Perceived barriers to treatment for adolescent depression. Med Care (2009) 1.04

The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction. J Acquir Immune Defic Syndr (2012) 1.03

Social networks, social support, and burden in relationships, and mortality after breast cancer diagnosis in the Life After Breast Cancer Epidemiology (LACE) study. Breast Cancer Res Treat (2012) 1.02

Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer (2011) 1.02

An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women. Vaccine (2012) 1.01

Lifestyle factors and survival in women with breast cancer. J Nutr (2007) 1.00

Body mass index measurement and obesity prevalence in ten U.S. health plans. Clin Med Res (2010) 1.00

The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. Cancer Causes Control (2013) 0.99

Long-term safety of radiotherapy and breast cancer laterality in older survivors. Cancer Epidemiol Biomarkers Prev (2011) 0.97

Red wine consumption and risk of prostate cancer: the California men's health study. Int J Cancer (2010) 0.95

Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev (2014) 0.95

Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr (2014) 0.94

A comparison of lifestyle and behavioral cardiovascular disease risk factors between Asian Indian and White non-Hispanic men. Ethn Dis (2012) 0.94

Generational status and duration of residence predict diabetes prevalence among Latinos: the California Men's Health Study. BMC Public Health (2009) 0.93

Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study. Breast Cancer Res Treat (2011) 0.93

Delayed radiotherapy for breast cancer patients in integrated delivery systems. Am J Manag Care (2009) 0.92

Evaluating racial/ethnic disparities in lower urinary tract symptoms in men. J Urol (2011) 0.91

Receipt of appropriate primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care. J Clin Oncol (2007) 0.91

Employment status and quality of life in recently diagnosed breast cancer survivors. Psychooncology (2012) 0.91

Use of Abacavir and Risk of Cardiovascular Disease Among HIV-Infected Individuals. J Acquir Immune Defic Syndr (2016) 0.89

Statins and breast cancer stage and mortality in the Women's Health Initiative. Cancer Causes Control (2015) 0.89

Recruiting pregnant smokers into a clinical trial: using a network-model managed care organization versus community-based practices. Prev Med (2007) 0.88

Risk of bleeding after percutaneous endoscopic gastrostomy (PEG). Dig Dis Sci (2011) 0.87

Does methodology affect the ability to monitor tobacco control activities? implications for HEDIS and other performance measures. Prev Med (2003) 0.87

Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction. J Urol (2011) 0.87

Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs (2009) 0.86

Long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer. Breast Cancer Res Treat (2013) 0.85

Correlates of prostate-specific antigen testing in a large multiethnic cohort. Am J Manag Care (2009) 0.84

Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study. BMC Urol (2013) 0.84

Correlates of screening sigmoidoscopy use among men in a large nonprofit health plan. Cancer (2007) 0.84

Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat (2014) 0.84

The burden of rhinitis in a managed care organization. Ann Allergy Asthma Immunol (2008) 0.83

Contribution of common medications to lower urinary tract symptoms in men. Arch Intern Med (2011) 0.83

Validation of Autism Spectrum Disorder Diagnoses in Large Healthcare Systems with Electronic Medical Records. J Autism Dev Disord (2015) 0.83

Racial disparities in erectile dysfunction among participants in the California Men's Health Study. J Sex Med (2009) 0.83

Asthma costs and utilization in a managed care organization. J Allergy Clin Immunol (2008) 0.83

Webinar Training: an acceptable, feasible and effective approach for multi-site medical record abstraction: the BOWII experience. BMC Res Notes (2011) 0.83

Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study. BMC Cancer (2014) 0.83

Trends in nonalcoholic fatty liver disease-related hospitalizations in US children, adolescents, and young adults. J Pediatr Gastroenterol Nutr (2009) 0.82

Alcoholic beverage intake and risk of lung cancer: the California Men's Health Study. Cancer Epidemiol Biomarkers Prev (2008) 0.82

A hybrid approach to identify subsequent breast cancer using pathology and automated health information data. Med Care (2015) 0.82

Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study. Breast Cancer Res Treat (2014) 0.82

Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting. Breast Cancer Res Treat (2011) 0.81

Risk factors of herpes zoster among children immunized with varicella vaccine: results from a nested case-control study. Pediatr Infect Dis J (2010) 0.81

Risk of skeletal-related events in patients with advanced prostate cancer treated with pamidronate or zoledronic acid. Ann Pharmacother (2010) 0.81

Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. Cancer Causes Control (2012) 0.81

Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer. Cancer Med (2012) 0.80

Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project. Breast Cancer Res Treat (2013) 0.80

The accuracy and trends of smoking history documentation in electronic medical records in a large managed care organization. Subst Use Misuse (2013) 0.79

Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study. Vaccine (2012) 0.79

Perceived support to stay quit: what happens after delivery? Addict Behav (2009) 0.79

Postdiagnosis cruciferous vegetable consumption and breast cancer outcomes: a report from the After Breast Cancer Pooling Project. Cancer Epidemiol Biomarkers Prev (2013) 0.78